ConfirmPDX - First-to-market ddPCR assay to better understand tumor composition
No more estimating. No more ranges. No more uncertainty.
When PDX models are transplanted into mice, human tumors can become contaminated with mouse cells, making it difficult to assess the impact of your treatment on a human tumor.
Lack of visibility into your results can diminish confidence in your therapeutic trials, reducing the likelihood of qualifying for human clinical trials.
In this webinar, you’ll have the chance to learn about ConfirmPDX, a new solution that improves the precision of your cell line characterizations so that you can move your research forward with confidence.
Meet the presenters
Sarah A. Hansen
DVM, MS, DACLAM
Scientific Affairs
Steve Smith
Ph.D, MBA
Senior Product Manager, Biologics
Fast, accurate, and reliable results from the team you know and trust.
Connect with IDEXX BioAnalytics today.